Clinical Trials Directory

Trials / Completed

CompletedNCT04205110

Development and Validation of a Fast, Semi-Automated Hybrid Imaging Platform to Assess Coronary Atherosclerotic Plaque Morphology, Endothelial Shear Stress and Arterial Inflammation: A Proof of Principle Study (VALID-PET-CT)

Status
Completed
Phase
Study type
Observational
Enrollment
7 (actual)
Sponsor
Barts & The London NHS Trust · Academic / Other
Sex
All
Age
40 Years
Healthy volunteers
Not accepted

Summary

Imaging the inside of coronary arteries (intravascular imaging) offers great insight into the assessment and treatment of coronary artery disease. Over time, substances such as fat, cholesterol and calcium can build up into 'plaques' in the arteries, causing narrowings or even blockages. These plaques can also rupture, causing cardiovascular events such as heart attacks or strokes. By using ultrasound and infrared technology, intravascular imaging can help assess these plaques, however this is an invasive technique involving angiography. Plaque composition, structure and stability can be affected by inflammation and the stress that the arteries are under. The investigators have pioneered novel minimally-invasive methods for modelling arterial stress using computed tomography coronary angiography (CTCA), as well as imaging coronary arterial inflammation using a positron emission tomography (PET) scan. Before embarking upon a large-scale clinical outcome study to determine whether these novel methods can improve risk prediction, the aim is to perform a proof-of-principle study to further develop our methodology for hybrid image analysis, and to validate this technique against high-resolution intravascular imaging as a surrogate marker of histology.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTPET-CTPET-CT compared to intravascular imaging for assessment of atherosclerotic plaques in stable angina patients

Timeline

Start date
2020-11-01
Primary completion
2023-10-10
Completion
2023-10-10
First posted
2019-12-19
Last updated
2025-02-06

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT04205110. Inclusion in this directory is not an endorsement.